With
the long-term and extensive abuse of antibiotics, bacteria
can mutate into multidrug-resistant (MDR) strains, resist the existing
antibiotics, and escape the danger of being killed. MDR bacteria-caused
skin infections are intractable and chronic, becoming one of the most
significant and global public-health issues. Thus, the development
of novel antimicrobial materials is urgently needed. Non-antibiotic
small molecule-modified gold nanoclusters (AuNCs) have great potential
as a substitute for commercial antibiotics. Still, their narrow antibacterial
spectrum hinders their wide clinical applications. Herein, we report
that 4,6-diamino-2-pyrimidinethiol (DAPT)-modified AuNCs (DAPT-AuNCs)
can fight against Gram-negative and Gram-positive bacterial strains
as well as their MDR counterparts. By modifying DAPT-AuNCs on nanofibrous
films, we develop an antibiotic film as innovative dressings for curing
incised wounds, which exhibits excellent therapeutic effects on wounds
infected by MDR bacteria. Compared to the narrow-spectral one, the
broad-spectral antibacterial activity of the DAPT-AuNCs-modified film
is more suitable for preventing and treating skin infections caused
by various kinds of unknown bacteria. Moreover, the antibacterial
films display excellent biocompatibility, implying the great potential
for clinical applications.